Crispr Therapeutics Ag (CRSP)

Net Income Growth

56.29%

Quarterly · Period ending:

CRSP logo

CRSP Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported56.29%
CRSP Quarterly Net Income YoY % (-160.80% → 56.29%)
High-resolution chart · PNG

CRSP net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Net Income Growth — Quarterly
Period endingNet Income Growth
56.2913%
9.6069%
-250.0657%
-23.8521%
-64.9809%
-16.6437%
-141.7597%
23.3701%
-62.6036%
-119.7136%
180.8022%
35.7476%
58.167%
70.3906%
21.7157%
-37.2748%
-124.4768%
-58.3707%
-31.9594%
-37.5534%
1,053.1297%
-62.2851%
-450.4649%
-166.7801%
-48.338%
-44.0485%
164.1773%
372.9644%
-39.914%
-71.053%
-33,851.773%
-105.2495%
-71.9919%
-31.7811%
-99.1753%
-68.1435%
-30.0105%
-154.3828%
239.1665%
-131.2559%
-371.1502%
-160.797%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.